Key Topics: - Emerging challenges in organ specific cancer research
- Biobanking international harmonization & globalization
- Immuno-oncology: new developments in solid tumor therapy
- The role of protein homeostasis in the genesis of cancer
- Epigenetic drivers of drug resistance
- Molecular targeted drug discovery: From concept to clinic
Key Speaking Organizations: - Celgene, USA
- Agenus & 4-Antibody AG, Switzerland
- Nanomerics Ltd, UK
- Imperial College London, UK
- Wolfgang Goethe-University, Germany
- Queen’s University Belfast, UK
- The British Association for Cancer Research, UK
- APeX Disease Reserch Institute, USA
The congress will be an excellent opportunity to meet global industry peers and learn about the latest developments in cancer diagnosis and therapy. We look forward to meeting you in London! Warm Regards,Oliver Smith Marketing Manager | MnM Conferences |